📖Étude complète :
Alain R. Thierry et al., Journal of Medical Virology, 2025; 97:e70613
🔗 maint.onlinelibrary.wiley.com
#LongCovid #Research #Science #Immunothrombosis #microclots #Apresj20
@resiapretorius.bsky.social
@inserm.fr
But sigh, people are still going to ask me “what has thrombosis got to do with kidney disease?” I remain one of the very few nephrologists who participate in #ISTH. #Immunothrombosis has got everything to do with vascular disease. #ISTH2025
Everyone on #NephSky knows RAAS inhibitors reduce MACE (arterial thrombosis), but understanding #immunothrombosis through the contact pathway (originally an immune pathway in evolutionary history), helps us understand the immunological connection between hypertension and thrombosis.
In fact, we should study the impact on outcomes of treating acute intercurrent viral disease in all cases of arteriovenous thrombosis. #immunothrombosis www.ahajournals.org/doi/10.1161/...
Plus there's more: @thjournal.bsky.social asked us to write a comprehensive update on #immunothrombosis and #thromboinflammation - another fun collab with Christoph Gold and Konstantin Stark @lmumuenchen.bsky.social
www.thieme-connect.com/products/ejo...
What I have been saying for years. Cardiovascular events are #immunothrombosis events. Hypertension is an immunological disorder with vascular end-points driven by #thromboinflammation.
7/ The molecular basis: SARS-CoV-2 infects endothelial cells through ACE2 receptors, triggering inflammation, immune responses, and hypercoagulability (overactive clotting). These reactions drive the ongoing vascular damage in Long COVID. #Immunothrombosis
It was an immense pleasure to host our 2nd #immunothrombosis Symposium @LMU Munich
together with Konstantin Stark. Talks and discussions were outstanding, and new ideas & perspectives made the meeting really special!
